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CYCLIC AMP, CYCLIC GMP, AND GLUCOCORTICOIDS AS POTENTIAL 
METABOLIC REGULATORS OF EPIDERMAL PROLIFERATION AND 
DIFFERENTIATION 
J OHN J . VOORHEES , M.D . , C YNTHI A L. MARCELO, PH .D., AND ELIZABETH A. DUELL, PH.D. 
Depart m ents ot Dermatology and Biological Chemistry, Univ ersity of Michigan M edical School , Ann Arbor, Michigan 
The two cyclic nucleotides, cyclic AMP a nd cycl ic GMP, appea r to be central to the 
metabo lic regulation of cell proliferation and differentiation in various cells. Moreover, in 
m~y systems glucocort ico ids appea r to act in concert with or parallel to cycl ic AMP. The 
availa ble ev idence suggests t hat t hese t hree molecu lar spec ies-cyclic AMP, cyclic GMP, 
a nd glucocorticoids-may be essen tial to th e normal regulation of ep iderm al proliferation 
and differentiation . 
In 1970, we suggested t hat perturbed epiderm a l homeostasis, exemplified by psorias is, 
might be associated wit h low cellular leve ls of cyclic AMP and , in 1972, with high levels of 
cyclic GMP as well. Subsequent measuremen ts of these two cyclic nucleotides in our 
laboratory showed a probable reduct ion in the cycl ic AMP/cycli c GMP ratio in lesional 
p soriatic tissue. This led to the hypothesis that the cardina l features of psoriatic epidermis-
glycogen accumulation , excessive proliferation , and reduced cell specia lization-are t he 
res ul t of t his reduced ratio. A coroll ary of this hypothesis was that a psoriatic lesion could not 
begin or exist without this a ltered cyclic nucleotide ratio. Recently, four different agents-
lithium, a beta adrenergic blocking agen t, ant imala rial s, a nd iodide-have been found to 
exacerbate psori asis a nd to reduce the formation of cycl ic AMP in various tissues. 
Consequently we believe t hat cyclic nucleotides are of cen t ra l importance in t he pathogenesis 
of 't he epiderm al component of psoriasis. 
The invo lved epidermis of the prototypic prolif-
erati ve skin disease psoriasis is characteri zed by 
excessive cell proliferation [1), incomplete termi -
nal different iation (2], glycoge n accu mulation (3 ], 
and the nearly com plete a bsence of the glyco-
prote in-rich ce ll surface in the spinous layer [4J . 
In 1970, when we began working on the molecu-
lar basis of psoriasis , t he following information was 
avai la bie: (1) Cyclic AMP inhibited t he in vi tro 
prolifer::).tion of polyoma virus-transformed ham-
ster cells [5 J and of H eLa and L cells [6 ). (2) In 
November , 1970, Johnson, Friedman, and Pastan 
[7] reported at the New York Academy of Sciences 
that after the addition of cycl ic AMP to sarcoma 
cells, the latter acquired some of t he morphologic 
and growth characteristics of nonmalignan t fibro-
blasts. (3) Cyclic AMP could stimulate t he b reak-
down of glycogen in liver and muscle [8 ]. (4) 
Epidermal cell divis ion is reversibly inhibited by 
epinephrine [9J. (5) Iversen [10J had speculated 
that t he action of so-called "epidermal cha lone" 
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(by rep utat ion a tiss ue-s pec ifi c, species -non-
specific inhibitor of mi tosis) might be mediated by 
the cycl ic AMP system . 
The then reported involvement of cyc li c AMP in 
in vitro control of cell proliferation, t he state of 
differe nt iation of cell s, a nd t issue glycoge n levels 
prompted us to suggest t hat psoriasis m ay resu lt 
from a defect in t he cycl ic AMP system of meta-
bolic regu lat ion in lesiona l ep idermis since t his 
t issue is ch aracterized by disturbances in t hese 
cyclic AMP-linked functions (11) . The resu lts of 
our initial investigations indicated t hat beta ad re-
nergic stimulation of cycl ic AMP formation could 
be dem onstrated in vit ro in epidermal slices (1 2 J, 
that a n isoproterenol-sens iti ve adenylate cyclase 
was present in a parti culate fraction of t he epider-
mis [1 3 ], and t hat isoproterenol, dibutyryl cycl ic 
AMP, and t heophylline could inhibit epide rmal 
cell proliferation [14 ]. 
Having th~s demonstrated t hat mamma lian 
epidermis conta ined a cycl ic AMP system capable 
of stimulation by beta adrenergic agonists and that 
an elevation in t he epidermal levels of t his cyclic 
nucleotide co uld inhibit epidermal ce ll divis ion in 
vit ro, we investigated t he levels of cyclic AMP in 
the psor iatic les ion. The results of this work have 
indicated that t he mean lesiona l levels of cycl ic 
AMP in t he psoriatic individual are probably less 
t han t hose in uninvolved epiderma l t issue (15,16 ]. 
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In this presentation , t he term " probable" or " prob-
ably" is used to refer to cycl ic nucleotide concen-
t rations and ratios because of the uncertainties 
resul t ing from the data- base problem which we 
discussed previous ly [15 ]. 
At the sa me ti me that we were investigating t he 
role of cycl ic AMP in epidermal homeostas i , other 
investigato rs were demonstrat ing in various tissue 
sys tems the ex istence and physiologic function , 
often the opposite from that of cycl ic AMP, of 
another second messenger, cyc lic GMP. T he ev i-
dence , recently discussed by us [17 ,18 ], suggested 
that in several organisms, cells, and t issues the 
leve ls of both these cycli c nucleotides induced a 
dualistic and biochemica lly multifocal (pleiotyp ic) 
response which could be central to the control of 
ce llular proliferation and differentiation . 
THE PLEIOT Yl' IC RESPO NSE, DUALISM , AND CYC LIC 
NUCLEOTlDES IN PROLIFERATION AND 
DIFFERENTIATION 
The term p leiotypic response is used to descri be 
a constant set of metabolically unrelated biochem-
ical reactions which respond in a coordinated 
manner when the in vitro growth condi t ions of 
mammalian cells are a ltered [19] . Although the 
mediator of thi s coordin ate response was ini t ia ll y 
thought to be ppGp p [19 ), the most recent avai la-
ble data indicate that the coord in ate effects of 
cyclic AMP and cyclic GMP may in part regulate 
mammalian cell responses to alte red in vitro envi-
ronmenta l condi t ions [20 ]. In these investigat ions, 
the pleiotypic response was s tudied by observing 
how t he add it ion and omission of serum affected 
t he transport rates of uridine, leucine, and 
2-deoxy-glucose of BALB/c 3T3 cell s in cul ture. 
The rates of t ransport of these s ubstances were 
decreased in serum-starved cells. The addition of 
serum increased the rate of t ransport of these 
molecul es, but t his effect was part ially blocked by 
the simul taneous addition of dibutyryl cyclic AMP ' 
and t heophylline, or prostaglandin EI (PGE I) 
(which rai se in tracellula r cycl ic AMP levels), to 
t he cell s. T he inclusion of cycl ic GMP in the se rum 
dibutyryl cyclic AMP + t heophylline blocked 
the cyclic AMP inhibition of transport rates, i.e., 
the transport of these substan ces in creased and the 
inhibi ted rates were restored to approx imately 
those of the serum contro ls. In this system, there-
fore , cycl ic AMP and cycl ic GMP had oppos ite 
effects on a set of reactions which are of great 
importan ce in the response of cultured ce lls to 
se rum ad di t ion . 
Working with the same cell cu lture system 
(BALB/c 3T3), Seifert and Rudland [21 J recently 
demonstrated an in crease in DNA synthesis after 
t.he add it ion of cycl ic GMP or its buty rated ana-
logues to quiescent ce lls in cul ture. They also 
observed that the in t racell ular levels of cycl ic 
GMP rose by a factor of 8- to ll- fold after t he 
addition of serum to resting cultures whereas the 
ce llul ar leve ls of cyclic AMP decreased 2- to 3-fold 
during the same period. One hour after t he addi-
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tion of serum , t he levels of both cycl ic nucleotides 
had returned to those of quiescent cultures. 
Using Swiss 3T 3-4A ce ll s and arresting cell 
c~lture grow~~ i~l various phases of t he ce ll cycle b y 
dIfferent a rtif iCia lly depleted cu lture media, Seif-
ert a nd Rud land [22 J have also reported t hat m ajor 
in creases in cyc li c GMP were observed when cell 
growth was reinitiated, but only when the cultures 
were arrested in the Go phase of the cell cycle. 
Cycl ic AMP exhibi ted rhythmi c changes t hrough_ 
out the ce ll cycle in addition to t he decrease in 
in tracellular levels observed in the GoG I t ransi-
tion of quiescent cul tu res in response to serU m 
addit ion. These in vest igato rs suggested t hat cycl ic 
GMP may be t he in trace llul ar activator of the 
pleiotyp ic ~nd mi toge nic program ~ f the cell [22] 
a nd that llltracellular concentratIOns of cyclic 
GMP and cycl ic AMP/cycli c GMP ratios are 
reliable indicators of the growth state of the cells 
[23 ). The in tracellula r concent rations and ratios of 
these cycl ic nucleotides and the changes in these 
parameters during cell proli feration may also indi -
cate the transformed state of cells in cu lture [23]. 
Pastan and J ohnson [24 J propose that " in trans-
formation the 'trans/a rming agent ', whether it be a 
virus , ca rcinogen or ioni zing radiation, lowers cy-
cli c AMP levels." Rud land, Seeley, and Seifert 
[23], invest igat ing cycl ic nucleotide shifts in grow-
in g, quiescent , and se rum-activated SV -3T3 
(transformed) ce ll cul tures, found greatly reduced 
shifts in cycl ic nucleotide leve ls, t he average ele-
vated levels of cyclic GMP being onl y tw ice those 
of the non t ransformed coun te rpart ce lt cultures. 
The effects of cycl ic AMP on t he ce ll cycle have 
been invest igated since the fluctuation of cyclic 
AMP levels may be of importance. Studying the 
regul atory effects of cycli c AMP in synchronized 
HeLa cells, Zeilig, Johnson, Friedman , Kumar, 
and Sutherland [25 J have reported that elevated 
levels of cycl ic AMP at the G 2 stage of t he cell cycle 
delay the transition of cell s from G 2 to M, that 
cycl ic AMP stimul ates the completion of meta-
ph ase (M), t hat augmentation of cyclic AMP at 
ea rl y G I (not mid or late GI) inhibits G h and that 
t he S phase of the cell cycle is not su bject to cyclic 
AMP regulation. Coffin o, Gray, and T omkins [26] 
observed that S49 mouse lymphoma t issue cul ture 
cells were inhibited in G I by dibutyryl cyclic AMP 
but that exogenously added dibu tyry l cycl ic AMP 
had no effect on S or G 2 + M . 
This evidence has estab lished that (1) a lterations 
in the in tracellula r levels of cycl ic GMP may be 
involved in the initial events that lead to cell pro· 
li feration (i.e., the Go ~ G I trans ition); (2) cyclic 
AMP may exert regulatory in!1uences throughout 
t he cell cycle by prolonging or inhibiting t he GI 
phase of the cycle [25- 28 j; this observation is im· 
portant since the G I phase is that part of the cell 
cycle in which the rate of cell proliferation (quie . 
cent or proliferating) is probably regulated physio. 
logica lly; (3) cycl ic AMP/cyclic GMP ratios are 
disturbed in proliferating cells (17 ,18}; and (4) 
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cyclic AMP may have a cent ra l role in the control 
of differe nt iated cell fun ctions possibly because of 
the aforement ioned regu lation of the cell cycle in 
the G, phase. 
The import.ance of cycl ic AMP/cycl ic GMP 
ratios in determining the proliferative- differen-
tiated state of cells and the oppos ing actions of 
these two nucleotides was suggested by Goldberg 
an d his co lleagues [29- 31 ]. The antago nistic rela-
tions hip between these two cycli c nucleotides in 
certain cell types with respect to proliferation- dif-
fere n t iation and many other physiologic processes 
was f irst proposed and term ed the " dualism " 
hypothesis of biolo~ical regulation by Goldbe,:g 
and hi s co lleagues 111 1972 [29 ]. Bas ica lly , t his 
hypothesis proposed that in bidirectional systems, 
i.e., where there are two opposing fun ctions, in -
creases in cycl ic AMP are necessary for one func-
tion to occur, and increases in cyc li c GMP (often 
with co ncomitant dec reases in cycl ic AMP) t rigger 
the opposite function. The fluctuations of cyclic 
AMP and cycl ic GMP and of the cyclic AMP/ 
cyclic GMP ratios in the ini t iation of cell growth 
fro m Go [21,22] appear to be an example of such a 
dualistic effect. 
. The accelerated metabolism of the psoriatic 
ep idermis (and a lso of ep idermal wound hea ling 
[32 ], the epidermal component of cutaneous atopy 
and skin cancer) seems ana logous to the pleiotypic 
response, i.e., the tissue responds at seem ingly 
unrelated biochemica l foci (proliferation , differen -
tiation, glycogen storage, and the cell surface) to 
some as yet unknown factor(s) possibly mediated 
by t hese two cyclic nucleotides. The observed 
shifts in t he cyclic AMP/cyclic GMP ratio which 
are implicated in t he control of cellul ar prolifera-
t ion a nd differentiation in the aforement ioned 
several less complex cell systems appear to 
strengthen our content ion that. the probable in-
creased ' cycl ic GMP and decreased cyc li c AMP 
levels in psoriatic les ions are central to the mis-
regulated growth of les iona l psoriatic epidermis. 
Other more circumstant ial ev idence can a lso be 
cited . Sunlight frequently improves psoriatic 
plaques, and visible light by in teracting with cycl ic 
AMP, cycl ic GMP phosphodiesterase(s) , and gua-
nylate cyclase [33- 36 ), decreases the cycli c GMP 
content of retinal t issue. Sunlight exposure (the 
wavelength not yet ri gorously defined) may have 
the same effect on cycl ic GMP levels in psoriatic 
lesions, i.e., it may cause a decrease in abnormally 
high cyclic GMP levels, thus presumably normal -
izing t he cyclic AMP/cyclic GMP ratio and switch-
ing t he lesion to its " normal" epidermal pheno-
type. The psoriatic plaque, with its increased 
vasodilation and thinned and leaky vessel walls 
[37 ), exposes the basal cells of lesional ep idermis to 
increased amounts of plasma prote ins [38 ]; this 
appears to be analogous to add ing serum to quies-
cent cell cul t ure systems which in creases in t racel-
lular cyclic G MP and lowers cycl ic AMP levels [21) 
concomitant with a stimulation of cell prolifera-
tion . 
PSORIASIS 
The metabolism of cyclic AMP and cycl ic GMP 
in the epidermis has recently been reviewed (17 ,-
18,39,40 ]. An adenyl ate cyclase (hormonally sensi -
t ive) (1 2,13,41 ], cycl ic nucleotide phosphod iester-
ase [39,42- 44 ], cyclic AMP-dependent protein ki-
nase [45,46 ], and guanylate cyclase [47 ] have been 
found in the epidermis or full-thickness skin . 
Alterations in cycl ic nucleotide metabolism may 
be important. for ini t iati ng and/or ma in tai ning the 
pso riat ic les ions [11 J. 
In our labora tory, cycl ic AMP levels have been 
determined in 50 patients by means of two differ-
ent assay techniques and three different data bases 
(DNA, protein, and wet weight) . From this we 
calculated 6 values for the cyclic AMP concentra-
tion in in volved vs uninvolved areas. Cycl ic AMP 
levels were stat istica lly significantly decreased 
(p < 0.005) in the lesions for 5 of the 6 calculated 
values . In one assay system using wet weight as 
the denominator for calculation, the decreased 
cycl ic AMP level was of borderline significance 
(p = 0.09). This data base, however, seems to be 
the least reliable because of variation in scale, 
edema, and hydration [15,16 ]. 
Since these resul ts indicate a probable decrease 
in the cyc li c AMP levels in the les ional a reas, the 
enzymes involved in cyclic AMP metabolism were 
investigated. We used an indirect method to mea-
sure t he activity of adenyl ate cyclase. S lices of 
ep idermal tiss ue were incubated with a nd without 
isoproterenol (1 X 10- 6 M). The levels of cycl ic 
AMP were t hen determined by the Gilman binding 
prote in assay (48 ]. Since a cyclic nucleotide phos-
phodiesterase (PDE) inhibitor was purposely not 
added to the system, the levels of cycl ic AMP 
reflected the difference between t he activities of 
adenylate cyclase and PDE and thus may have 
approx imated in vivo conditions . After 3 min of 
incubation with isoproterenol (IPR) , there was no 
s ignificant difference in the cyclic AMP levels in 
t he involved and uninvolved samples [39 J, a possi-
ble indication that no gross defect exists in the 
a denylate cyclase- receptor complex. At later time 
points , the level of cyclic AMP seemed to decrease 
faster in the involved areas than in the unin volved 
areas (49 ]. In preliminary experiments, an increase 
in PDE activity had been detected in t he lesional 
areas [42 J. The more rapid decrease in the cyclic 
AMP levels in the lesional area after stimulation 
with IPR [4.9 ] may refl ect this increase in PDE 
activity in the psoria t ic lesion. 
Two other laboratories have reported results 
which appear to be incompatible with our data on 
t he stimulability of adenyl ate cyclase and the 
tiss ue levels of cycl ic AMP. A defect in adenylate 
cyclase activity has been reported by two different 
laboratories [50- 54 ]. Halprin et" al have reported 
that the stimulabili ty of the adenylate cyclase by 
epinephrine was decreased in t issue samples ob-
tained from lesional areas [55 ]. The a ddi tion of 
PGE, to the involved t issue also resulted in a 
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decrease in the stimulabi li ty of adenylate cyclase 
[56] whereas PGE2 [54] stimulated the adenylate 
cyclase in both the involved and the uninvolved 
t issue to the same extent. 
An increase in the cyclic AMP leve l in involved 
areas has been reported [53 ]. This report is diffi-
cult to reconcile with the observed increase in t he 
glycogen content of the psoriatic les ion both histo-
logically [3] and biochemically [57] and the de-
crease in phosphorylase a act ivity in the lesion 
[58 ], since cyclic AMP is critica lly important in the 
control of glycogen metabolism via the regulation 
of phosphorylase a activity [8]. Increased levels of 
cyclic AMP result in an increased degradation of 
glycogen (KM Halprin and associates , persona l 
communication) in the lesion probably because of 
an increase in phosphorylase a activ ity in the 
tissue. Moreover, in earlier sections of this paper , 
references were cited and discussed which indicate 
that increased leve ls of cycl ic AMP are associated 
with the inhibition of cell proliferation and the 
induction of cell differentiation. Variation in meth-
odology may partially explain the disparate results 
obtained on cellular cyclic AMP levels and en-
zymatic activity assoc iated with cyclic AMP syn-
thesis. 
FACTORS WHICH MAY AFFECT THE DATA ON CYCLIC 
NUCLEOTIDES IN PSORIASIS 
The preparation of the biopsy sites, the depth of 
the biopsy, the methods for the partial purification 
(or lack of partial pu rification), and the assay of 
cyclic AMP differ markedly in each of the three 
laboratories investigating the role of cyclic AMP in 
psoriasis . In our laboratory, the biopsy site is 
anesthetized with lidocaine without ep inephrine. 
Halprin et al [55 J either use no anesthesia or freeze 
the area with ethyl chloride, and the other labora-
tory does not indicate the preparative procedure . 
The injection of the loc'al anesthetic may uncouple' 
an increase in cyclic AMP levels from the usual 
metabolic effects that occur as a result of increased 
cyclic AMP [59,60) with a minimal to modest 
elevation of cyclic AMP levels at high concentra-
tions (1 X 10- 3 M) of local anesthetic [59,60]. 
The possibility that cyclic AMP leve ls were 
altered because of an ischemic effect produced by 
the fluid volume of the lidocaine has also been 
considered since, in other tissues , ischemia can 
elevate cyclic AMP levels [61] . Involved and unin-
volved areas of psoriatic patients as well as skin of 
normal volunteers are injected with lidocaine with-
out epinephrine. Involved tissue is removed prior 
to uninvolved epidermis. Although the involved 
tissue is removed and snap frozen in liquid nitro-
gen within 5 sec, the entire techn ical procedure 
involving hemostasis and bandaging of the in-
volved area is such that the uninvolved area is 
removed approximately 2 min later. Since the 
uninvolved area has had local anesthetic in place 
for this time, the fluid volume of the anesthetic has 
a 2-min potential opportunity to produce a cyclic 
AMP rise due to ischemia. From normal volunteers 
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only one epidermal area is removed without a 
2-min time lag. 
Therefore, if the anesthetic f1uid volume were 
producing an ischemic effect on epidermal cyclic 
AMP levels, the concentration of cyclic AMP in 
uninvolved epidermis should be higher than in 
epidermis from volunteer control subjects. Halprin 
et a l find that ischemia in t he skin produces a 1000/. 
increase in cyclic AMP in less t han 30 sec (55] . A; 
examination of Tables 1 and 2 in our earli er work 
[15] shows that the percent increase in un involved 
vs volun teer epidermis was 1.1%, 40%, and 0% 
based on protein , DNA, and wet weight, respec. 
t ively. This provides no substantial support for the 
argument by Halprin et al [55 J that Our decreased 
cycl ic AMP levels in involved vs uninvolved tissue 
are the result of an ischemia-produced cyclic AMP 
rise due to the previously described 2-min time lag 
before removal of uninvolved epidermis. 
The values obtained for the cyclic AMP levels by 
the methods used by Halprin et al [55) (no 
anesthesia or freez ing of the tissue) may be the 
sum of the cAMP produced by t he procedures at 
the time of biopsy and the endogenous levels of the 
nucleotide. If the ep idermal sample is removed 
without anesthesia, the pa in felt during the actUal 
keratoming of t he epidermis probably results in t he 
massive system ic release of epinephrine or the local 
release of norepinephrine which may stimulate 
adenylate cyclase in the epiderm is resulting in 
increased cyclic AMP levels. Under such condi. 
tions one might raise the involved cyclic AMP level 
such that no difference could be detected in 
involved vs uninvolved t issue. 
Exposure of animals to cold (4°C) produces large 
increases in cyc lic AMP levels [62,63) which may 
be neurohormonal in origin. An additional consid. 
eration is the instability of some adenyl ate cyclase 
to freezing . S ince cell membranes or the cell 
surface may be a ltered in t he lesion [4], the 
adeny late cyclase receptor complex may be dam. 
aged by the ethyl ch loride spray freez ing proce 
used by Halprin et al [55). In our experience, 
psoriatic epidermal sli ces frozen in liquid nitrogen 
lose a considerable degree of stimulability by 
epinephrine when thawed once and incubated. The 
main point is t hat regard less of the method se. 
lected, a certain margin of error may be introduced 
into the values for cyclic AMP leve ls in the tissue,' 
Only further investigation wi ll determine which 
technique produces the least amount of change ill 
the cyclic AMP levels before and during th~ 
biopsy . 
Different laboratories have chosen different 
depths which they consider the most suitable for 
subsequent procedures and therefore the depth al ~ 
which the psoriasis biopsy is removed . For manyofj 
the psoriasis les ions, the routi ne depth of 0.2 mm 
used by two of the laboratories performing this 
type of investigation [53,55] leaves as much as 50~ 
of the proliferative and glycogen-containing com· 
partments on the patient. The cyclic AMP levels 
are probably lowest in the areas of rapid prolifera, 
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tion and glycogen storage, on the basis of data in 
the li terature derived fro m othe r sy te ms. Thus, 
leaving a significant portion of these two compart-
ments on the patient makes it impossible to 
ana lyze the major areas suspected of contain ing 
lower levels of cyclic AMP . In our opin ion, a ll of 
the proliferat ive compart ment must be in cluded in 
the analysis; therefore a depth of more t han 0.2 
mm is requ ired for a psoriasis biopsy. Other 
methodology is req uired to determine the leve ls of 
cyclic AMP in t he various layers of the ep idermis 
an d su ch methodo logy is currently being developed 
in our labo rato ry. 
The methods of purifying cycl ic AMP in the 
tissu e extracts and of analyzi ng the amoun t pres-
ent in th e t iss ue a lso differ . For the ana lysis of 
cycl ic AMP or cycl ic GMP to be accurate, t he 
samples must be part ially purified to remove 
competin g nucleotides for either t he binding pro-
te in or the an tibody in the rad ioimmunoassay. In 
additi on to the nucleotides, unidentifi ed compo-
nen ts in t he tissue extracts in terfere wit h or in 
some cases a ugment the binding of cycl ic AMP to 
the proteins in question. Since the standard curves 
do not conta in t hese materials, t he information 
may be in accurat~ unless at least a partia l purifi-
cat ion is accomplished. Column chromatograp hy 
or a comparable tec hnique is thus req uired to assay 
cyclic AMP in ep idermis. 
To correct for losses during the purification 
procedure, it is important t hat the recovery of 
add ed la bel ed cycli c nucleotide be determined as a 
means of assessing t he percentage of t issue cyc lic 
AMP actua lly assayed. The results from over 100 
biops ies in our own laboratory indicate t hat the 
recovery of carri er nucleotide is 66.5% ± 10.6 SD 
fo r t he unin volved and 65 ± 1l.4 SD for the 
involved samples. An occas iona l sam ple, however, 
will be displaced from this mean rather markedl y 
(the most extre me values obtained were 29% and 
96% recovery). Routinely, any sample that does not 
have a recovery of at least 45 to 50% is discarded . 
However, the recoveries are of value only if t hey a re 
calcu lated from the same piece of t issue on which 
the cycl ic AMP ana lys is was performed ; otherwise 
an addit iona l error arisin g from incorrect compen-
sat ion can augment the value of an atyp ica l resu lt. 
Unfortun ately, when the micromethod of Halprin 
et a l [55 ] is used, the cycl ic AMP recovery cannot 
be determined in the same spec im en in whic h the 
cyc lic AMP level is measured. 
T he use of the adenine prelabeling tec hnique has 
yielded useful information about the hormonal 
respons iveness of a given tiss ue. However, if dis-
eased vs normal ti ssue is compared as H alprin et al 
[55) have done, several possibly incorrect assump -
tions must be m ade. What is measu red is not the 
actual amoun t of cycl ic AMP but the ratio of 
counts in the cycl ic AMP pool vs t he tota l counts in 
the ATP pool. This is a valid mathematica l mani p-
ulation only if a s ingle ATP pool exists in t he en tire 
cell. Since t his is not known (in fact , there are 
indications that several ATP pools ex ist within a 
cell), this assumption may be invalid a nd thus 
casts dou bt on the resul ts. A valid resu lt will be 
achieved only when numerous techniques are used. 
In add ition to the numerous tec hnica l problems 
discussed above, the question of previous medica-
t ion must a lso be considered. It is well known that 
glucocort icoids are widely used to t reat p oriasis. 
How these glucocorticoids act is unknown , but 
they proba bly i[lcrease cycl ic AMP leve ls by cer-
tain indirect mechanisms [64]. Occasiona lly pa-
tients do not want to disappoin t us or slow down 
the research and neglect to te ll us that they have 
used topica l agents within a week before the actual 
biopsy period. Thus the differences we have ob-
served may be smaller than wou ld occur in un -
treated areas because of an undisclosed stero id 
t reatment before biopsy. 
Having discussed the drawbacks and advantages 
of the tec hniques ava il ab le and t heir resu lts, we 
wish to in tel:ject a few general comments here. We 
believe that the ratio of cyclic AMP to cycli c GMP 
as wel l as the abso lut.e va lues are important in 
main taining homeostasis in the epidermis. Certa in 
reported data indicate that only very slight 
changes in the levels of cyclic AMP are necessary 
to effect substant ia l changes in a metabolic param-
eter [65 ]. For example, a 17% dec rease in t he leve ls 
of cycl ic AMP can resul t in the release of histamine 
[66] or a change of 0.36 picomoles of cyclic AMP 
can sti mul ate steroidogenesis to 60% of the max-
imum [67]. T hus the a ltered cycl ic AMP/cycl ic 
GMP ratio that we have reported may well be a 
change of sufficient magnitude to rnismod ul ate the 
ep iderm is . 
The uneq ui vocal presence of glycoge n and in-
creased proli fe ration as weoll as a ltered differentia -
tion in psoriatic epidermis may well be due to 
small quantitative changes in the level of cycl ic 
AMP or in the ratio of cyclic AMP/cyclic GMP. Of 
the 50 patients used in our studies to determine the 
cycl ic AMP levels in the epidermis, 13 on the basis 
of wet weight, 7 on the bas is of prote in , and 5 on 
the basis of DNA have had higher levels of cyclic 
AMP in the involved epidermis t han in the paired 
uninvolved sample. In a few cases, the cyclic AMP 
levels have been the same in the paired samples 
(Tab. n. Therefore, we are speaking in terms of a 
mean decrease in cyclic AMP. T hus, when one is 
dealing with sma ll changes in highly dynamic , 
rapidly metaboli za ble compounds, large num bers 
of sa mples are required to obtain an acc urate 
picture of the significance of these compounds in 
cell functiOlt. If a mean decrease in the cyc lic 
AMP/cyclic GMP ratio is important in initiating 
and/or maintaining the psoriatic lesion (and voJe 
believe it is), t hen an actua l decrease in cycl ic 
AMP levels or in the ratio of cycl ic AMP to eycl ic 
GMP is necessary. The current information in the 
variety of cell systems discussed in the previous 
sections supports this hypothes is. In view of these 
experimental caveats, the problem of how nega-
t ive data are interpreted in general (i.e., the data 
of Halprin et al [55] in this case) and the apparent 
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TABLE I. Numb er of patients containing the sam e or 
higher leve ls of cyclic AMP in the lesion versus 
uninvolved areas in 50 patients 
T he b iopsy sam ples were kel'atomed at a depth 'ufTi -
cien L Lo includ e a ll or most of t he p rolifera ti ve compart-
men t in t he biopsy . T he cyclic AM P in t he ti ssue extract 
was partia lly pu rified by column chrom atography a nd 
assayed wit h t he G il man binding protein or t he Brooker 
isotopic displ ace ment method . Pe rce n t recovery was 
calculated for eac h of t he samples a na lyzed. 
Cyclic AMP levels 
Data base 
Sameu Higher 
Wet we igh t 4 13 
D NA 6 5 
Protein 7 
a T he va lues obta ined for t he pa ired sa mples were 
wit hi n 5% of each other. 
role of th ese t wo cycli c nucl eotides in c?nt rolling 
growth and diffe rent iat ion in general, It can be 
prudent ly conclud ed tha t th e r~ is no c~ange in the 
les iona l cyclic nucleot ide ratio only If unusua lly 
ri gorous experim ents have been conducted . T~us 
fa r we a re not awa re t hat such ex perImentatIOn 
has been done. 
DRUGS T HAT EXACERBATE PSORI ASIS 
T he importance and cent ra li ty of altered cyclic 
nucleotide metabolism in t he pathogenesis of pso-
ri as is are furt her attested to by t he fact t hat dru gs 
which exacerbate psori as is also prevent t he accu -
mulation of cyclic AMP in ce rtain t issues. 
We are aware of 6 patients whose psori as is was 
exacerbated a nd in fact rendered uncontroll able by 
doses of li t hium carbonate which gave a li t hiuf!! 
blood level (~ l.0 mEq / li ter) that controll ed their 
concomita nt manic-depress ive psychos is. This was 
. first reported in 1972 in 3 psoriat ic patients by 
Carte r [68 ) who observed a p?s i ~ i ve c.orrela.t io.n 
between exace rb ation and remiss ion of psorI as Is 
when patien ts went on and off t he li t hium doses 
t hat cont roll ed t he ir psychos is. In 2 of t hese 3 
pat ients, methotrexate and topica l glucocort ico i.d 
did not cont rol t he psori as is when therapeut ic 
doses of li t hium were being given at t he same t ime, 
bu t did cont rol it when the pat ients were off 
li t hium or when t he blood leve ls of li t hium 
dropped below t he t herapeut ic range. for mania. 
S ince Carte r 's report [68 ], 3 other patients whose 
pso ri asis was exace rb a ted by li thium have come to 
our attent ion * 
Lit hi um a ffects ion t ransport systems and a lso 
in terfe res wi t h t he accumul at ion of cyclic AM P in 
a wide variety of t issues [69 J. In t he spr ing of 1974, 
Carte r perfo rm ed experiments in our laborato ry 
which were des igned to determine whether li t hium 
could reduce t he isoproterenol-induced accumula-
t ion of cycli c AMP in s li ces of psoriatic epidermis. 
• Carroll B (2 cases), an d Ha rrell ER (1 case). persona l 
communication, 1974 . 
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His prelimin ary data in 5 patients indicate t h at 
li thium carbonate 1 mEq/ li ter (5 x 10- ' M) r e-
duced by approxim ate ly 50% the in t raepiderm al 
cyclic AMP levels t ha t can accumulate when eith er 
involved or uninvolved psori ati c epidermis is inc u -
bated in isoprote renol (l X 10- 6 M) wi t hout CYclic 
nucleotide phosphodiesterase inhibi tors. This work 
is being cont inued in more psoria tic pati ents a nd 
in norm al volun teers to determine whether t h e 
pso ri at ic epiderm a l cyclic AMP system is m ore 
suscept ible to li t hium inhibi t ion th an that of 
norma l subjects. 
S hell ey has described 2 patients in whom iodine 
prec ipi tated generali zed psori asis [70 J, and R a p o_ 
port and lngbar have shown that iodine reduces t h e 
abili ty of T SH to promote the accumul ation of 
cyclic AMP in t he t hyroid [71) . In certain psoriatic 
pat ien ts , iodine, like li thium , m ay be a ble to 
reduce epiderm al cyclic AMP acc umulation . An -
tim ala rials, we kn ow, can exacerbate psori asis a nd 
also inhibit plate let adenylate cyc lase [72 ) and t h e 
hormone-induced acc umulation of cyclic AMP in 
fat cell s [731. P erhaps in certain psoriatic patien ts, 
lithium , iod ine, a nd an t im a la ri a ls l ~ssen the a bil . 
ity of t he epidermis to ge nerate cycl iC AMP . These 
possibili t ies are under current investigation in Our 
la boratory. 
If circul ating epinephrin e or periphera lly re-
leased norepinephrine (the beta adrenergic compo_ 
n en t) have any physiologic cont rol over t he epider-
mis via cyclic AMP, psoriatic patients being 
treated wi th beta adrenergic blockin g agents for 
other diseases should at times experience some 
ex ace rbation . Three publications [74- 76 ) from 
Engla nd report pso ri as iform eruptions in patien t 
taking a beta adrenergic blocking age nt. P erhaps 
in these individuals psori as is was latent and be-
came active when beta blockade impa ired b eta 
sympathet ic epiderm al tone which in t urn reduced 
epiderm al cycli c AMP levels to a n extent t hat 
fl orid psori as is occurred . These reports of psoriasis 
exace rbated by four chemica lly unrelated agents 
which can reduce cyclic AMP leve ls in certain 
t issues and our demonstration th at one of t h em 
(li t hium ) can affect t he psoria ti c epidermis di-
rectly are of some importance . They suggest: (1) 
that the impaired cyclic AMP metabolism in 
psori as is may be prim ary to the epiderm al patho-
physiology of t he disease, and (2) th at since t hese 
drugs may a lter the cyc lic AMP content of the 
epidermis to prec ipitate a n are, it may be impossi-
ble to m a in ta in epiderma l homeostas is wi thout 
suffi cient epiderm a l cyc li c AMP . We regard the 
involved psoriat ic epidermis as the prototype of 
deranged epiderm a l homeostasis. 
GLUCOCORTICO IDS AND CYCLIC AMP 
Topica l glucocort ico ids are t he most effi cac ious 
therapeuti c agents for most common pro liferativ~ 
skin diseases. Their mechanism of action , however, 
is not yet clear [77 ). T hey a re clea rly cutan eoll 
vasoconstri ctors [77 J and can inh ibi t prolife ration 
in t he G I and G 2 phases of the epiderm al cell cycl~ 
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[78,79], as well as in other ce ll s [80 ]. Such inhibi-
tion of epiderma l proliferation may be indirect (via 
vasoconstri ct ion) or direct (via action on t he ep i-
dermal cells). 
Intracellular glucocorticoid receptors are present 
in m ost if not all mammalian ce ll s a nd are though t 
to m ed iate most effects of glucocorticoids (81). In 
p ure epidermal ce lls of neon atal mice, t r iamci no-
lone aceton ide at a concentration of 1 x 10- 8 M 
produced ~45% inhibi tion of growth when added 
to t he cul t ures at an appropri ate time (Voorhees, 
Duell , a nd Kelsey , unpublished data). T herefore, 
epidermis probably contains glucocortico id recep-
tors, and at least part of t he inhibit ion of prolifera-
tion m ay be by direct glucocortico id binding to 
these receptors. At sim ilar low doses, glucocorti-
co id accelerates ep iderm al keratini zation by both 
morphologic (82,83) and biochemical criteria (84, 
85 ) presumably by binding to such receptors. 
Electron microscopy shows that t he glucocorticoid-
induced epidermal-specific proteins [84 ) are asso-
ciated with increased numbers of tonofilaments 
(85 ]. These inducib le ep iderma l proteins [85) may 
be the resul t of glucocorticoid sti mul ation of epi-
derm a l RN A polymerase [86 ) since glucocortico ids 
' are t hough t to stimul ate t he formation of specific 
proteins by derepressing their corresponding genes 
directly to stimulate the synthesis of mRNA for t he 
affected proteins [87 ). Thus glucocorticoids may be 
a ble to m odul ate the growth and differentiation of 
epidermis as has been shown in other t issues (81). 
G lucocorticoids and cycl ic AMP induce similar 
fu nctions in cells; t his has been extensively re-
viewed by Thompson and Lippman [64]. In ge n-
eral , metabolic signa ls induced by cycl ic AMP and 
glucocorticoid appear to move the cell in parallel 
di rections [64 ]. For example, glucocorticoids in -
hibit proliferation [78,79 ) and stimul ate differen t i-
ation in epidermis [82-85], and cyclic AMP inhib-
its th e G 2 [88-90 J and possibly the G, [91,92,t J 
phase of t he ep idermal cell cycle. Whether cycl ic 
AMP stimul ates epidermal differentiation has not 
been demonstrated , but future experiments may 
show t hat it does since relatively undifferen tiated 
feta l epiderm is [93- 95], like psoriatic ep iderm is, 
contains much glycogen [3,57 J. In psoriatic epider-
mis, agen ts which elevate cycl ic AMP a lso stimu-
late glycogen breakdown (KM Halprin a nd assoc i-
ates, personal communication ). We suggest t hat 
exogenous or endogenous cycl ic AMP may do t he 
same in fetal ep idermis as maturation occurs. 
However, whether the disappearance of glycogen 
and the stimul ation of epidermal differen t ia-
tion-specialization are meaningfully correlated re-
main s to be seen . 
T hat cyclic AMP participates in t he stimulation 
of epiderm al di ffe ren t iation is suggested by t he 
fact t hat it appears to be involved in the induction 
of differen t iation in such other cells 'as hepatocytes 
t Dahl MGC, Shuster S: Epidermal GIS-phase block 
by cycl ic AMP and a serum fa ctor (abstr) .. Fourth 
Meeting of the European Society for Derm atologica l 
Research, Amsterdam, Netherlands, 1974 . 
[96], myogenic ce ll s [97 ], lens epitheli a l cells [98], 
a nd neuroblasto ma ce lls [99,100 ]. Moreover, both 
glucocort icoids [101 ] and cycl ic AMP [102] inhi bit 
proliferation a nd kill lymp hoid cell s in culture. 
This parallel act ion of cycl ic AMP and glucocort i-
co ids can be extended to t he molecular level 
because , depending on the t issue in question , both 
can eit her stimulate or inhibi t s pecifi c RNA a nd 
protein syn thes is [64,103] . 
Although the effects of glucocort ico ids and cyclic 
AMP are remarkably parallel , their mode of action 
appears to be different [64 ]. T he best evidence of 
t his is the work of Bourne, Coffino, Melmon , 
Tomkins, and Weinste in (104 ). Using lymphoid 
mutants, t hey have shown that cyc li c AMP-res ist-
ant mutant cell s are normally sens it ive to glucocor-
t ico id cytolys is. These data [1041 are espec ially 
important s in ce t hey strongly s uggest that t he 
parallelis m of action of cyclic AMP a nd glucocort i-
co ids is not entirely exp lained by the well -known 
but poorly understood " permissive effects" of glu -
cocort icoids on cyclic AMP-mediated fu nctions 
[64]. 
T he pe rmissive effects (physio logic concentra-
tions) of glucocorti co ids have been shown or sug-
gested to be involved at severl:l l points in the 
regulatory sequence of cycl ic AMP: (1) the mainte-
n ance of in tracellular ions such as Ca ++ which is 
t hought to pl ay an important role in cellular cycli c 
AMP respons iveness [105 J; (2) th e restoration of 
ep inephrine-induced glycogen phosphorylase acti-
vation in hea rts from adrena lectomized rats [106] ; 
(3) t he induction of adenylate cyc lase synthesis 
[107 ]; (4) t he restoration of beta receptor respon -
siveness to catecholamines [108 ]; (5) t he biosyn-
thesis of cell surface hormone receptors or other 
surface molecul es important to growth contro l 
[109 ]; (6) t he biosyn thes is of a spec ific coupling 
factor responsible for coupling t he hormonally 
activated cell surface receptor to adenyl ate cyclase 
[110) . 
S ince the cycl ic AMP system is affected at 
multiple points by glucocorti co ids, the parallel 
function s of cyclic AMP and glucocort ico id could 
be expla ined by t hese interactionS. However, the 
previously mentioned data of Bourne et a l [104 ] 
suggest that at some point the mechanism of 
action of these two agents cannot be solely due to 
glucocortico id support of cyclic AMP-mediated 
processes . Therefore cycl ic AMP and glucocorti -
coids probably function both independently or in 
concert, but with a similar result. In addit ion , 
glucocorticoids can lower the cellular leve ls of 
cyc lic GMP in rena l and pulmonary t issue [29 J. 
TREATMENT OF PROLIFERATIVE SKIN DISEASE BY 
NORMALIZ ING THE CYC LIC AMP/CyCLIC GMP RATIO 
It should be appare nt from t he above discuss ion 
that maneuvers des igned to norml:l li ze t he cycl ic 
AMP/cycl ic GMP ratio as well as to increase the 
cyclic AMP a nd glucocorti co id content of the 
epidermis might well provide a more efficac ious 
resul t than either alone. We believe t hat t he cyclic 
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AMP content of t he involved psoriatic epidermis is 
reduced. For those who prefer t he resul ts of Har-
konen , Hopsu-Havu, and Raij [53] and of Halprin 
et al [55], namely, that the cellular leve ls of cyclic 
AMP a re either elevated or a re not reduced in the 
psoriatic lesion , t he pharmacologic elevation of 
lesional cyclic AMP may nevertheless be of interest 
a nd h ave potential therape utic benefit. One reason 
for such interest is t hat t he data given by Ha lprin 
et al [55 J suggest t hat t he les ional epiderm is is less 
responsive to cycl ic AMP elevating agents. If t his 
observation is borne out in the in vivo s it uation 
and is to have any importance in proliferative skin 
disease, perhaps the coroll ary is that the "normal 
level of cyclic AMP in psoriasis" should be raised 
t herapeutica lly to a level higher than normal. Such 
a maneuver could be beneficial because in non-
transformed fibroblasts [28 ] conta ining presum-
ably normal levels of cyclic AMP, the exogenous 
addition of cycl ic AMP inhibi ts growth in the G I 
phase of t he cell cycle. Furthermore, fetal brain 
cells in primary culture (111] can be differentiated 
by cycl ic AMP. It has also been shown in primary 
cu lt ures of epidermal ce lls that cyclic AMP elevat-
ing agents inhibit proliferation in t he G 2 [88- 90] 
and quite possibly in t he G I phase of the ce ll cycle 
a lso [91,92,H 
Here we wish to mention other studies which 
suggest that the use of agents capable of elevatin g 
cyclic AMP levels in the epidermis may be bene-
ficial regard less of whether the reader prefers ou r 
data or those of HarkOnen, Hopsu-Havu, a nd Raij 
[53 ] or Halprin et al [55 ). In a recent double-b lind 
study of 1% top ica l papaverine cream vs cream 
a lone, a statistically sign ifi cant result was ob-
tained . The clinical response, however, was 
infer ior to that of most topical glucocortico id 
formu lations. T he possible reasons for this have 
recently been discussed (11 2) . Us ing topical theo-
phylline and cycl ic AMP in psoriasis, Laugier et al 
[113J observed some improvement. Moreover, Bel -
man and T roll have prevented t he appearance of 
skin carcinomas in mice by topical dibutyryl cycl ic 
AMP and theophylline [114 ]. In a study from 
China, remarkable results were achieved without 
any serious s ide effects by the intram uscul a r injec-
tion of dibutyryl cyclic AMP in 25 psoriatic pa-
tients, on ly 3 of whom showed no improvement 
[115]. We have discussed the Ch inese study in 
detail elsewhere lI8 ]. 
Adenosi ne raises cyclic AMP in the brain [116] 
via a probable cell surface adenosine receptor and 
produces a s imilar rise in the cellular levels of 
cycli c AMP in neu roblastoma cells [117]. In both 
the brai n and the neuroblastoma cell s, t his action 
is blocked by theop hylline which is thought to 
compete with adenosine for t he receptor at t he ce ll 
surface [118 ]. We ha ve shown that adenos ine raises 
cyclic AMP in t he epidermis in vitro and that this 
effect is blocked by theophylline (Tab. II). We 
have treated approximately 50 patients with in-
t ramuscu la r 5'AMP with beneficial results in about 
75%, with 25% of the 75% clearin g almost com-
Vol. 65, NO.1 
pletely. Of perhaps more than passing in terest i 
the fact that 5' AMP itself a lso elevates in traepi_ 
dermal cycl ic AMP levels (D uell , Bazner, and 
Voorhees, unpublished data). We have discussed 
t his in detail elsewhere (18). In none of t he abOve 
studi es except t he papaverine study was a double, 
blind design used . Therefore, the results reviewed 
above could represent a placebo effect . However 
the 5' AMP treatment program we have been usin' 
is encouraging enough to warrant a double-blin~ 
study. In no study, including t he papaverine study 
~ave we attempted to .dem~nstrate a rise in th~ 
II1tr~ep.lderm.al leve ls of cycliC Al'1P III t he in vivo 
ps~natIc les lol~. All demonstrations 0.c e levateQ 
ep idermal cycl iC AMP have been done III vitro. h. 
t he case of 5' AMP our working hypothesis is that it 
a rrives at t he ep iderma l cell surface where the eel! 
surface enzyme, 5'n ucleotidase, con verts th 
5' AMP to adenos ine with a resultant rise in epider: 
mal cycl ic AMP. We have shown that the cycli 
AMP leve ls increase in epidermal sli ces in vitro ilC 
the presence of either 5'AMP or adenosine. \ 
We should like to point out that cycl ic AMP m al' 
be involved in the unexp lained abil ity of metho'. 
trexate (MTX) to preferentially affect psoriati 
lesions rat her t han unin volved areas . In leukemiC 
cells, the ce llul ar level of cyclic AMP is thought t r 
affect the transport of MTX into the cell, that iso 
low cellular leve ls of cycli c AMP favor MT~ 
transport in to the cells whereas high levels block it 
[1 ~9). ~h~ther s llch a m~chanism operates ill 
epiderm iS IS not known. S mit h a nd Gelfant [1 20] 
howe~e:, have. observed d~mage? ~prematurely 
keratmlzed ) epiderm al cells 111 psorIat ic lesions but 
not in uninvolved areas of patients on MTX. Mor~ 
MTX may have entered t hese epiderm al cells 
because of low cellula r levels of cycli c AMP. 
TABLE Il . Theophy lline inhibition of increased cyclic 
AMP levels in heratomed mouse epidermal slices after Q 
5-min incubotion with adenosine 
Keratomed sli ces of hairless mouse ep idermis we~ 
preincubated ["or 20 min at 37°C in Krebs-Ringer solu tion 
and glucose. Five minutes after the addition 0[" adenosin! 
or adenosine plus theophylline to the experimental fl ask, 
samples were removed a nd qui ck frozen in liquid nit ro-
gen. T he cyclic AMP levels were assayed with the Gil l11 l1Jl 
binding protein method after partial purification bv 
colu mn chromatography. The numbers in parenthesis 
indicate the number of ind ependent experiments pet,' 
formed at each adenosine concentration . 
Molar concentration 
of a denosine 
5 X 10- " 
5 X 10- ' 
7 X 10- ' · 
1 X 10- 3 
5 X 10- 3 
8 X 10- ' 
1 X 10- 2 
% Increase in cyclic 
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